Lv7
5005 积分 2020-09-07 加入
脑胶质瘤靶向和免疫治疗专家共识(2025版)
16天前
已完结
脑胶质瘤放射治疗专家共识（2025版）
16天前
已完结
胶质瘤分子病理诊断中国专家共识（2025版）
16天前
已完结
抗血管靶向药物相关性高血压的治疗进展
3个月前
已完结
Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes: The OASIS 2 Randomized Clinical Trial
5个月前
已完结
Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes: The OASIS 2 Randomized Clinical Trial
5个月前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
FDA-approved drug labeling for the study of drug-induced liver injury
6个月前
已完结
皖公网安备34019202002308
